Kangchen Pharmaceutical: Hemocoagulase Agkistrodon for Injection Receives New Veterinary Drug Registration Certificate, with a 3-year Monitoring Period

Kangchen Pharmaceutical announced that the Ministry of Agriculture and Rural Affairs Announcement No. 1062 approved the new veterinary drug application for the Hemocoagulase Agkistrodon for Injection jointly filed by the company and its wholly-owned subsidiary Beijing Aixinwan Pharmaceutical Technology Co., Ltd. The registration certificate number is New Veterinary Drug Certificate No. 113. It is indicated for hemostasis in canine surgical bleeding, with a monitoring period of 3 years. The company will actively advance the work related to the veterinary drug product approval number.